STATE-OF-THE-ART PAPER
Atherothrombosis and High-Risk Plaque
Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging
Valentin Fuster, MD, PhD, FACC*,
Zahi A. Fayad, PhD, FACC*,*,
Pedro R. Moreno, MD, FACC*,*,
Michael Poon, MD, FACC*, ,
Roberto Corti, MD, FACC and
Juan J. Badimon, PhD, FACC*
* Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Cardiovascular Health Center, The Mount Sinai School of Medicine
Cabrini Hospital, New York, New York
Zurich University Hospital, Zurich, Switzerland
Manuscript received July 14, 2004;
revised manuscript received December 23, 2004,
accepted March 4, 2005.
* Reprint requests and correspondence: Dr. Pedro R. Moreno and Dr. Zahi A. Fayad, Mount Sinai School of Medicine, Box 1030, New York, New York 10029. (Email: Pedro.Moreno{at}msnyuhealth.org).
This second part of the review on atherothrombosis highlights the diffuse nature of the disease analyzing the feasibility and potential of the noninvasive imaging modalities, including computed tomography (electron-beam computed and multi-detector computed tomography) and magnetic resonance imaging for its detection and monitoring. These imaging modalities are being established as promising tools in high-risk cardiovascular patients for identification and/or management of coronary calcification, stenotic or obstructive disease, high-risk plaques (not necessarily stenotic), and overall burden of the disease. In addition, such technology facilitates the understanding of the processes involved in the development and progression of atherothrombosis responsible for coronary, cerebral, and peripheral ischemic events.
|
Abbreviations and Acronyms
| | CAC = coronary artery calcium | | CS = calcium score | | CT = computed tomography | | EBCT = electron-beam computed tomography | | HU = Hounsfield units | | MDCT = multi-detector computed tomography | | MRA = magnetic resonance angiography | | MRI = magnetic resonance imaging | | SSFP = steady-state free precession |
|
This article has been cited by other articles:

|
 |

|
 |
 
R. W. Bauer, C. Thilo, S. A. Chiaramida, T. J. Vogl, P. Costello, and U. J. Schoepf
Noncalcified Atherosclerotic Plaque Burden at Coronary CT Angiography: A Better Predictor of Ischemia at Stress Myocardial Perfusion Imaging Than Calcium Score and Stenosis Severity
Am. J. Roentgenol.,
August 1, 2009;
193(2):
410 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hyafil, J.-C. Cornily, J. H.F. Rudd, J. Machac, L. J. Feldman, and Z. A. Fayad
Quantification of Inflammation Within Rabbit Atherosclerotic Plaques Using the Macrophage-Specific CT Contrast Agent N1177: A Comparison with 18F-FDG PET/CT and Histology
J. Nucl. Med.,
June 1, 2009;
50(6):
959 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Ronald, Y. Chen, A. J.-L. Belisle, A. M. Hamilton, K. A. Rogers, R. A. Hegele, B. Misselwitz, and B. K. Rutt
Comparison of Gadofluorine-M and Gd-DTPA for Noninvasive Staging of Atherosclerotic Plaque Stability Using MRI
Circ Cardiovasc Imaging,
May 1, 2009;
2(3):
226 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Lipinski, K. C. Briley-Saebo, V. Mani, and Z. A. Fayad
"Positive Contrast" Inversion-Recovery With Oxide Nanoparticles-Resonant Water Suppression Magnetic Resonance Imaging: A Change for the Better?
J. Am. Coll. Cardiol.,
August 5, 2008;
52(6):
492 - 494.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Calcagno, J.-C. Cornily, F. Hyafil, J. H.F. Rudd, K. C. Briley-Saebo, V. Mani, G. Goldschlager, J. Machac, V. Fuster, and Z. A. Fayad
Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET
Arterioscler Thromb Vasc Biol,
July 1, 2008;
28(7):
1311 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Guzman, D. M. Brinkley, P. M. Schumacher, R. M.J. Donahue, H. Beavers, and X. Qin
Tibial Artery Calcification as a Marker of Amputation Risk in Patients With Peripheral Arterial Disease
J. Am. Coll. Cardiol.,
May 20, 2008;
51(20):
1967 - 1974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yanai, H. Yoshida, Y. Tomono, and N. Tada
Atherosclerosis imaging in statin intervention trials
QJM,
May 1, 2007;
100(5):
253 - 262.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Levy, J. E. Levy, S. Kalet-Litman, R. Miller-Lotan, N. S. Levy, R. Asaf, J. Guetta, C. Yang, K. R. Purushothaman, V. Fuster, et al.
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque
Arterioscler Thromb Vasc Biol,
January 1, 2007;
27(1):
134 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Waxman, F. Ishibashi, and J. E. Muller
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
Circulation,
November 28, 2006;
114(22):
2390 - 2411.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. F. Klein, P. C. Lavallee, P. J. Touboul, E. Schouman-Claeys, and P. Amarenco
In vivo middle cerebral artery plaque imaging by high-resolution MRI.
Neurology,
July 25, 2006;
67(2):
327 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Feinstein
Contrast Ultrasound Imaging of the Carotid Artery Vasa Vasorum and Atherosclerotic Plaque Neovascularization
J. Am. Coll. Cardiol.,
July 18, 2006;
48(2):
236 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Willinek
Looking Beyond the Lumen to Predict Cerebrovascular Events: "The Road Less Travelled By"
Stroke,
March 1, 2006;
37(3):
759 - 760.
[Full Text]
[PDF]
|
 |
|
|